Your search returned the following 16 documents:

16. Comparison of Envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates
    M.-W. Welker, Christoph Welsch, D. Ochs, W. P. Hofmann, E. Herrmann, A. Piiper, R. W. Hartmann, S. Zeuzem, C. Sarrazin, and Bernd Kronenberger
    Journal of Viral Hepatitis 18 (3): 181-192, 2011
    
15. Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevir
    Wolf Peter Hofmann, Tje Lin Chung, Carola Osbahr, Simone Susser, Ursel Karey, Ulrike Mihm, Christoph Welsch, Jörn Lötsch, Christoph Sarrazin, Stefan Zeuzem, and Eva Herrmann
    Antiviral Therapy 16 (5): 695-704, 2011
    
14. Dimerization of the hepatitis C virus nonstructural protein 4B depends on the integrity of an aminoterminal basic leucine zipper
    Martin-Walter Welker, Christoph Welsch, Aline Meyer, Iris Antes, Mario Albrecht, Nicole Forestier, Bernd Kronenberger, Thomas Lengauer, Albrecht Piiper, Stefan Zeuzem, and Christoph Sarrazin
    Protein Science 19 (7): 1327-1336, 2010
    
13. Effect of ribavirin on the frequency of RNAse L cleavage sites within the hepatitis C viral genome
    Ulrike Mihm, W.P. Hofmann, Christoph Welsch, A. Polta, Thomas Lengauer, Stefan Zeuzem, Christoph Sarrazin, and E. Herrmann
    Journal of Viral Hepatitis 17 (3): 217-221, 2010
    
12. HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection
    Christian Markus Lange, Kirsten Roomp, Anette Dragan, Jacob Nattermann, Monika Michalk, Ulrich Spengler, Viola Weich, Thomas Lengauer, Stefan Zeuzem, Thoma Berg, and Christoph Sarrazin
    Journal of Hepatology 53 (6): 1022-1028, 2010
    
11. Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.
    Simone Susser, Christoph Welsch, Yalan Wang, Markus Zettler, Francisco S. Domingues, Ursula Karey, Eric Hughes, Robert Ralston, Xiao Tong, Eva Herrmann, Stefan Zeuzem, and Christoph Sarrazin
    Hepatology 50 (6): 1709-1718, 2009
    
10. Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C
    Ulrike Mihm, Oliver Ackermann, Christoph Welsch, Eva Herrmann, Wolf Peter Hofmann, Natalia Grigorian, Martin Walter Welker, Thomas Lengauer, Stefan Zeuzem, and Christoph Sarrazin
    Journal of Hepatology 50 (1): 49-58, 2009
    
9. Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of HCV
   Christoph Welsch, Francisco S. Domingues, Simone Susser, Iris Antes, Christoph Hartmann, Gabriele Mayr, Andreas Schlicker, Christoph Sarrazin, Mario Albrecht, Stefan Zeuzem, and Thomas Lengauer
   Genome Biology 9 (1): R16 p., 2008
   [PDF: Download: Welsch2008.pdf]
   
8. Correlation nonstructural (NS)4B amino acid variations with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients
   Martin W. Welker, Wolf-Peter Hofmann, Christoph Welsch, Michael von Wagner, Eva Herrmann, Thomas Lengauer, Stefan Zeuzem, and Christoph Sarrazin
   Journal of Viral Hepatitis 14 (5): 338-349, 2007
   
7. Identification and in silico characterization of a novel compound heterozygosty associated with hereditary aceruloplasminemia
   Wolf Peter Hofmann, Christoph Welsch, Yoshitomo Takahashi, Hiroaki Miyajima, Ulrike Mihm, Christoph Krick, Stefan Zeuzem, and Christoph Sarrazin
   Scandinavian Journal of Gastroenterology 42 (9): 1088-1094, 2007
   
6. Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases
   Wolf Peter Hofmann, B. Fernandez, E. Herrmann, Christoph Welsch, Ulrike Mihm, B. Kronenberg, G. Feldmann, U. Spengler, Stefan Zeuzem, and Christoph Sarrazin
   Journal of Viral Hepatitis 14 (7): 484-491, 2007
   
5. Structural and functional comparison of the non-structural protein 4B of flaviviridae
   Christoph Welsch, Mario Albrecht, Jochen Maydt, E. Herrmann, M.W. Welker, C. Sarrazin, A. Scheidig, Thomas Lengauer, and S. Zeuzem
   Journal of Molecular Graphics and Modeling 26 (2): 546-557, 2007
   
4. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C
   Ulrike Mihm, Natalia Grigorian, Christoph Welsch, Eva Herrmann, Bernd Kronenberger, Gerlinde Teuber, Michael von Wagner, Wolf-Peter Hofmann, Mario Albrecht, Thomas Lengauer, Stefan Zeuzem, and Christoph Sarrazin
   Antiviral Therapy 11 (4): 507-519, 2006
   
3. Association of HCV-related mixed cryoglobulinemia with specific mutational patterns of the HCV E2 protein and CD81 expression on peripheral B lymphocytes
   W.P. Hofmann, E. Herrmann, B. Kronenberger, Christian Merkwirth, Christoph Welsch, Thomas Lengauer, S. Zeuzem, and C. Sarrazin
   Blood 104 (4): 1228-1229, 2004
   
2. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection
   Christoph Sarrazin, Ulrike Mihm, Eva Herrmann, Christoph Welsch, Mario Albrecht, Ulrike Sarrazin, Stella Traver, Thomas Lengauer, and Stefan Zeuzem
   The Journal of Infectious Diseases 192 (10): 1710-1719, 2005
   
1. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
   Thomas Lengauer, Mario Albrecht, C. Sarrazin, U. Mihm, E. Herrmann, Christoph Welsch, U. Sarrazin, S. Traver, and S. Zeuzem
   Journal of Infectious Diseases 192 (10): 1710-1719, 2005